The global market for Cell and Tissue Preservation was valued at US$ 3,445 Million in 2021 and is estimated to reach US$ 9,189 Million by 2030 with a CAGR of 11.5% from 2022 to 2030.

Human tissue, blood, and serum samples are the starting materials for clinical and scientific research into a variety of serious human disorders. A number of critical techniques and processes must be used to maintain tissues and cells obtained for research purposes. Furthermore, the most widely used procedures, cryopreservation and hypothermic storage, have application and assessment flaws. Accurate sample assessment is required for successful utilization of human tissue samples and preserved cells. Because of the delayed beginning of cell death caused by preservation, membrane-integrity studies performed immediately after thawing sometimes produce erroneous results.

Market Dynamics

The rising research and development activities for the cell and tissue sector in various regions are a major driver driving the cell and tissue preservation market. The ability to replace organs and tissues on demand could save or enhance millions of lives each year throughout the world, providing public health advantages comparable to cancer cures. Transplantation, regenerative medicine, drug development, and a number of fast emerging topics spanning biomedicine are all hampered by unmet needs for organ and tissue preservation. Over the last decade, tissue preservation technologies and subsequent techniques leading to histological sections have remained mostly unchanged. Some of the approaches discussed in this chapter are still considered cutting-edge. Unfortunately, much research material is thrown out due to a lack of understanding and treatment of the material outside of histology laboratories, as well as a poor study design.

Increasing trend of cryopreservation is expected to boost the cell and tissue preservation industry. Tissue cells, microorganisms, small multicellular organisms, established cell lines, and complex biological structures such as embryos, nucleic acid, creatures, and proteins are all preserved by cryopreservation. To freeze cells, a variety of types of serum or media are applied. The most popular used alternatives are dimethyl sulfoxide (DMSO) and glycerol. Both alternatives are mixed with serum or medium in a liquid, and the cells are then set and frozen in a fluid nitrogen freezer. Tissue preservation procedures and subsequent techniques leading to histological sections have remained mostly unaltered over the last decade. Unfortunately, much research material is discarded due to a lack of knowledge and care of the material outside of histology facilities, as well as inadequate study design.

Market Insights

Type, product, application, end-user, and region are the five segments of the global cell and tissue preservation industry. The type segment is further bifurcated into tissues (blood, bone, soft tissues, skin, and others) and cells (mammalian cells and others (microorganisms and plant cells)). Based on product, the segmentation includes equipment (freezers, thawing equipment, refrigerators, storage systems, others), bio preservation media (home-brew media and pre-formulated media), and software. Therapeutics, drug discovery, research & development, and others (clinical trials and cosmetics) are the categorization of application segments. Furthermore, the end-user segment is categorized into hospitals, biobanks, and others.

Global Cell and Tissue Preservation Market Regional Competition

North America, Europe, Latin America, Asia-Pacific, and the Middle East & Africa are the segmentation of the global cell and tissue preservation industry. Among all the regions, North America acquired the lion’s share in 2021 due to the increased healthcare investments and advancements in biomedical research. Furthermore, growing research & development activities in the region is also one of the primary factors that are supporting the market demand. On the other hand, the Asia-Pacific region is likely to gain a significant impetus during the forecast period. The Asia-Pacific market's expansion has been propelled by pharmaceutical corporations' increasing involvement in the capitalization and use of preservation equipment.

Global Cell and Tissue Preservation Industry Segment Analysis

Cell and Tissue Preservation Market By Type

·         Cells

o   Mammalian Cells

o   Others (Plant Cells and Microorganisms)

·         Tissues

o   Bone

o   Blood

o   Skin

o   Soft Tissues

o   Others

Cell and Tissue Preservation Market By Product

·         Bio Preservation Media

o   Pre-Formulated Media

o   Home-Brew Media

·         Equipment

o   Refrigerators

o   Freezers

o   Thawing Equipment

o   Storage Systems

o   Others

Cell and Tissue Preservation Market By Application

·         Therapeutics

·         Drug Discovery

·         Research & Development

·         Others (Clinical Trials and Cosmetics)

Cell and Tissue Preservation Market By End-User

·         Hospitals

·         Biobanks

·         Others

Cell and Tissue Preservation Market Leading Companies

This section of the report identifies the market's major players. Agilent Technologies, Inc., Lonza, Avantor, Inc., Merck KGaA, FUJIFILM Irvine Scientific, Cytiva, BioLifeSolutions Inc., AMSBIO, Corning Incorporated, Thermo Fisher Scientific, Inc., STEMCELL Technologies Inc., BD, LGC SeraCare, Princeton CryoTech, CellGenix GmbH and the key companies mentioned in the research.

Cell and Tissue Preservation Market Regions